Literature DB >> 25132394

Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.

J Borley1, C Wilhelm-Benartzi, J Yazbek, R Williamson, N Bharwani, V Stewart, I Carson, E Hird, A McIndoe, A Farthing, S Blagden, S Ghaem-Maghami.   

Abstract

OBJECTIVE: To assess site of disease on preoperative computed tomography (CT) to predict surgical debulking in patients with ovarian cancer.
DESIGN: Two-phase retrospective cohort study.
SETTING: West London Gynaecological Cancer Centre, UK. POPULATION: Women with stage 3 or 4, ovarian, fallopian or primary peritoneal cancer undergoing cytoreductive surgery.
METHODS: Preoperative CT images were reviewed by experienced radiologists to assess the presence or absence of disease at predetermined sites. Multivariable stepwise logistic regression models determined sites of disease which were significantly associated with surgical outcomes in the test (n = 111) and validation (n = 70) sets. MAIN OUTCOME MEASURES: Sensitivity and specificity of CT in predicting surgical outcome.
RESULTS: Stepwise logistic regression identified that the presence of lung metastasis, pleural effusion, deposits on the large-bowel mesentery and small-bowel mesentery, and infrarenal para-aortic nodes were associated with debulking status. Logistic regression determined a surgical predictive score which was able to significantly predict suboptimal debulking (n = 94, P = 0.0001) with an area under the curve (AUC) of 0.749 (95% confidence interval [95% CI]: 0.652, 0.846) and a sensitivity of 69.2%, specificity of 71.4%, positive predictive value of 75.0% and negative predictive value of 65.2%. These results remained significant in a recent validation set. There was a significant difference in residual disease volume in the test and validation sets (P < 0.001) in keeping with improved optimal debulking rates.
CONCLUSIONS: The presence of disease at some sites on preoperative CT scan is significantly associated with suboptimal debulking and may be an indication for a change in surgical planning.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Computed tomography; ovarian cancer; preoperative assessment; surgical debulking

Mesh:

Year:  2014        PMID: 25132394     DOI: 10.1111/1471-0528.12992

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  11 in total

Review 1.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 2.  CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.

Authors:  Maria Clara Fernandes; Ines Nikolovski; Kara Long Roche; Yulia Lakhman
Journal:  Radiology       Date:  2022-05-24       Impact factor: 29.146

3.  Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.

Authors:  G M Nieuwenhuyzen-de Boer; W Hofhuis; N Reesink-Peters; S Willemsen; I A Boere; I G Schoots; J M J Piek; L N Hofman; J J Beltman; W J van Driel; H M J Werner; A Baalbergen; A M L D van Haaften-de Jong; M Dorman; L Haans; I Nedelcu; P C Ewing-Graham; H J van Beekhuizen
Journal:  Ann Surg Oncol       Date:  2022-05-13       Impact factor: 4.339

Review 4.  CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning.

Authors:  Anju Sahdev
Journal:  Cancer Imaging       Date:  2016-08-02       Impact factor: 3.909

Review 5.  Role of tumor microenvironment in ovarian cancer pathobiology.

Authors:  Alia Ghoneum; Hesham Afify; Ziyan Salih; Michael Kelly; Neveen Said
Journal:  Oncotarget       Date:  2018-04-27

6.  Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis.

Authors:  Ting Wen Yi Hu; Dan Nie; Jin Hai Gou; Zheng Yu Li
Journal:  Cancer Manag Res       Date:  2018-07-16       Impact factor: 3.989

7.  Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.

Authors:  Joline F Roze; Jacob P Hoogendam; Fleur T van de Wetering; René Spijker; Leen Verleye; Joan Vlayen; Wouter B Veldhuis; Rob Jpm Scholten; Ronald P Zweemer
Journal:  Cochrane Database Syst Rev       Date:  2018-10-08

Review 8.  Update on Imaging of Ovarian Cancer.

Authors:  Rosemarie Forstner; Matthias Meissnitzer; Teresa Margarida Cunha
Journal:  Curr Radiol Rep       Date:  2016-04-09

9.  Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer.

Authors:  Wankyu Eo; Hong-Bae Kim; Yong Joo Lee; Dong Soo Suh; Ki Hyung Kim; Heungyeol Kim
Journal:  J Cancer       Date:  2016-08-11       Impact factor: 4.207

10.  Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.

Authors:  Isabelle Thomassin-Naggara; Edouard Poncelet; Aurelie Jalaguier-Coudray; Adalgisa Guerra; Laure S Fournier; Sanja Stojanovic; Ingrid Millet; Nishat Bharwani; Valerie Juhan; Teresa M Cunha; Gabriele Masselli; Corinne Balleyguier; Caroline Malhaire; Nicolas F Perrot; Elizabeth A Sadowski; Marc Bazot; Patrice Taourel; Raphaël Porcher; Emile Darai; Caroline Reinhold; Andrea G Rockall
Journal:  JAMA Netw Open       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.